Rick Schafer
Stock Analyst at Oppenheimer
(4.80)
# 84
Out of 5,161 analysts
177
Total ratings
65.64%
Success rate
22.15%
Average return
Main Sectors:
Stocks Rated by Rick Schafer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SMTC Semtech | Reiterates: Outperform | $81 → $100 | $82.12 | +21.78% | 12 | Mar 10, 2026 | |
| NVDA NVIDIA | Reiterates: Outperform | $265 | $182.82 | +44.95% | 27 | Feb 26, 2026 | |
| ADI Analog Devices | Reiterates: Outperform | $350 → $400 | $308.33 | +29.73% | 24 | Feb 19, 2026 | |
| AVGO Broadcom | Maintains: Outperform | $435 → $450 | $334.90 | +34.37% | 22 | Dec 12, 2025 | |
| MRVL Marvell Technology | Reiterates: Outperform | $115 → $150 | $89.13 | +68.29% | 18 | Dec 3, 2025 | |
| MPWR Monolithic Power Systems | Maintains: Outperform | $700 → $800 | $1,025.18 | -21.96% | 21 | Jul 15, 2025 | |
| VECO Veeco Instruments | Reiterates: Outperform | $40 → $35 | $30.88 | +13.34% | 13 | Feb 7, 2025 | |
| NXPI NXP Semiconductors | Maintains: Outperform | $330 → $300 | $193.62 | +54.94% | 11 | Nov 6, 2024 | |
| TXN Texas Instruments | Maintains: Perform | n/a | $192.78 | - | 8 | Apr 24, 2024 | |
| AKTS Aktis Oncology | Maintains: Outperform | $6 → $3 | $19.26 | -84.42% | 5 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7 → $6 | $1.36 | +340.76% | 2 | Jun 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $79.00 | - | 4 | Jan 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $120 | $80.54 | +48.99% | 1 | Dec 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $268 | $45.50 | +489.01% | 1 | Nov 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $133.09 | - | 8 | Mar 1, 2017 |
Semtech
Mar 10, 2026
Reiterates: Outperform
Price Target: $81 → $100
Current: $82.12
Upside: +21.78%
NVIDIA
Feb 26, 2026
Reiterates: Outperform
Price Target: $265
Current: $182.82
Upside: +44.95%
Analog Devices
Feb 19, 2026
Reiterates: Outperform
Price Target: $350 → $400
Current: $308.33
Upside: +29.73%
Broadcom
Dec 12, 2025
Maintains: Outperform
Price Target: $435 → $450
Current: $334.90
Upside: +34.37%
Marvell Technology
Dec 3, 2025
Reiterates: Outperform
Price Target: $115 → $150
Current: $89.13
Upside: +68.29%
Monolithic Power Systems
Jul 15, 2025
Maintains: Outperform
Price Target: $700 → $800
Current: $1,025.18
Upside: -21.96%
Veeco Instruments
Feb 7, 2025
Reiterates: Outperform
Price Target: $40 → $35
Current: $30.88
Upside: +13.34%
NXP Semiconductors
Nov 6, 2024
Maintains: Outperform
Price Target: $330 → $300
Current: $193.62
Upside: +54.94%
Texas Instruments
Apr 24, 2024
Maintains: Perform
Price Target: n/a
Current: $192.78
Upside: -
Aktis Oncology
Sep 7, 2023
Maintains: Outperform
Price Target: $6 → $3
Current: $19.26
Upside: -84.42%
Jun 9, 2023
Maintains: Outperform
Price Target: $7 → $6
Current: $1.36
Upside: +340.76%
Jan 13, 2022
Downgrades: Perform
Price Target: n/a
Current: $79.00
Upside: -
Dec 20, 2021
Maintains: Outperform
Price Target: $175 → $120
Current: $80.54
Upside: +48.99%
Nov 9, 2021
Maintains: Outperform
Price Target: $329 → $268
Current: $45.50
Upside: +489.01%
Mar 1, 2017
Downgrades: Perform
Price Target: n/a
Current: $133.09
Upside: -